Peter Vanderslice, PhD

Dr. Vanderslice has spent over 20 years leading teams focused on the development of small molecule compounds that bind and modulate the function of integrins and chemokine receptors. The majority of his professional career has been in the pharmaceutical industry, where he gained familiarity with each stage of the pipeline from discovery to progression into clinical trials. Dr. Vanderslice has led teams working on several pre-clinical programs involving efforts in drug screening, lead compound characterization, and the development of preclinical animal models.

See Publications

Texas Heart Institute Positions

Interests

  • Non-invasive diagnostic imaging technologies

Education

  • Undergraduate:

    University of Maryland

  • Postgraduate:

    University of Texas at Austin (PhD)

  • Fellowships:

    University of California San Francisco

Honors, Awards and Memberships

Publications

Recent News

Stretchy Semiconductor Films Provide New Tools for Regenerative Medicine Research and Beyond

As part of their continued effort to devise new treatment options for patients with heart failure and other cardiovascular diseases,...

Sharing Our Latest Research With the World

Our Professional Staff members have demonstrated a commitment to advancing cardiovascular science. This can be seen in their research output....

The Texas Heart Institute Research Symposium 2022: A Day to Celebrate Innovation, Collaboration, and Translation

During its annual day-long Research Symposium on October 20, 2022, The Texas Heart Institute community came together in the Denton...